Lakefront Biotherapeutics NV (MEX:GLPGN) Marketable Securities: MXN60,778 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:GLPGN Lakefront Biotherapeutics NV MEX:GLPGN
58 GF Score
Price MXN665.65
GF Value MXN3,143.44
! 4 Warning Signs
View Full Analysis

What is Lakefront Biotherapeutics NV Marketable Securities?

Lakefront Biotherapeutics NV MEX:GLPGN 58 Marketable Securities is MXN60,778 Mil as of Mar. 2026. GuruFocus rates MEX:GLPGN with a GF Score™ of 58/100 and a GF Value™ of MXN3,143.44. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Lakefront Biotherapeutics NV's Marketable Securities for the quarter that ended in Mar. 2026 was MXN60,778 Mil.

Lakefront Biotherapeutics NV's annual Marketable Securities increased from Dec. 2023 (MXN65,115 Mil) to Dec. 2024 (MXN66,680 Mil) but then declined from Dec. 2024 (MXN66,680 Mil) to Dec. 2025 (MXN61,358 Mil).

Lakefront Biotherapeutics NV  (MEX:GLPGN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Lakefront Biotherapeutics NV Marketable Securities Related Terms

Lakefront Biotherapeutics NV Marketable Securities Historical Data

* Premium members only.

The historical data trend for Lakefront Biotherapeutics NV's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lakefront Biotherapeutics NV Marketable Securities Chart

Lakefront Biotherapeutics NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57,249.34 74,058.88 65,114.81 66,680.02 61,358.11

Lakefront Biotherapeutics NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70,536.22 65,583.71 64,283.42 61,358.11 60,778.23
MEX:GLPGN
58GF Score
Lakefront Biotherapeutics NV MEX:GLPGN
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lakefront Biotherapeutics NV Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of MXN60,778 Mil mean?
Lakefront Biotherapeutics NV (MEX:GLPGN) has a Marketable Securities of MXN60,778 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Lakefront Biotherapeutics NV and its competitors.
Is Lakefront Biotherapeutics NV's Marketable Securities too high?
Lakefront Biotherapeutics NV's current Marketable Securities is MXN60,778 Mil. Overall, Lakefront Biotherapeutics NV has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Lakefront Biotherapeutics NV's Marketable Securities compare to VRTX and REGN?
Lakefront Biotherapeutics NV's Marketable Securities of MXN60,778 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Lakefront Biotherapeutics NV and its competitors. Lakefront Biotherapeutics NV's current Marketable Securities is MXN60,778 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lakefront Biotherapeutics NV stock overvalued right now?
Lakefront Biotherapeutics NV (MEX:GLPGN) has a current Marketable Securities of MXN60,778 Mil. The stock's GF Value™ is MXN3,143.44, compared to a current price of MXN665.65 — trading 78.8% below its estimated fair value. The current Marketable Securities is MXN60,778 Mil. Lakefront Biotherapeutics NV's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Lakefront Biotherapeutics NV (MEX:GLPGN), the current Marketable Securities is MXN60,778 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lakefront Biotherapeutics NV (MEX:GLPGN) Overvalued in 2026?

Based on GuruFocus' analysis, Lakefront Biotherapeutics NV stock appears to be undervalued. The current stock price of MXN665.65 is trading 78.8% below its estimated GF Value™ of MXN3,143.44.

Key valuation signals for MEX:GLPGN:

  • Marketable Securities: MXN60,778 Mil
  • GF Value™: MXN3,143.44 vs. price of MXN665.65 (78.8% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the MEX:GLPGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lakefront Biotherapeutics NV Business Description

Address Schalienhoevedreef 20 T, Mechelen, BEL, 2800
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
58GF Score

Get the complete analysis for MEX:GLPGN

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN665.65
Price
MXN3,143.44
GF Value